| Title |
Ranbaxy agrees to pay $500 million drug safety settlement
|
|---|---|
| Published in |
Reactions Weekly, May 2013
|
| DOI | 10.1007/s40278-013-3239-y |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2024.
All research outputs
#7,727,332
of 23,493,900 outputs
Outputs from Reactions Weekly
#25
of 319 outputs
Outputs of similar age
#66,600
of 196,505 outputs
Outputs of similar age from Reactions Weekly
#3
of 60 outputs
Altmetric has tracked 23,493,900 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 319 research outputs from this source. They receive a mean Attention Score of 2.4. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,505 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.